Abstract
Oxidative stress is considered one of the causative pathomechanisms of nervous system diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, stroke and excitotoxicity. The basal expression of six different peroxiredoxin (Prx) isozymes show distinct distribution profiles in different brain regions and different cell types. PrxI and VI are expressed in glial cells but not in neurons; while PrxII, III, IV and V are expressed in neurons. Various diseases or models show altered expression levels of these isozymes, such as by upregulation of PrxI, II and VI and downregulation of PrxIII. Thioredoxin (Trx)I mRNA is distributed widely in the rat brain. This distribution pattern may reflect the specific functions of these isozymes. Recently, the neuroprotective roles of Prx III and V against ibotenate-induced-excitotoxicity were reported by two independent groups. Adenovirus transduction of PrxIII eliminated protein nitration and prevented gliosis caused by direct infusion of ibotenate. Systemic administration of recombinant PrxV diminished brain lesions in animals treated with ibotenate. In this chapter, we review the causative mechanisms of oxidative stress in neurodegenerative diseases, as well as describe the basal and disease-induced changes in Prxs/Trxs/Trx reductases expression levels and neuroprotective roles of Trxs and Prxs as demonstrated in overexpression models
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexandrova, M., Bochev, P., Markova, V. Bechev, B., Popova, M., Danovska, M., Simeonova, V., 2004, Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome. J. Clin. Neurosci. 11: 501–506.
Andoh, T., Chock, P.B., Chiueh, C.C., 2002, The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. . J. Biol. Chem. 277: 9655–9660.
Asahina, M., Yamada, T., Yoshiyama, Y., Yodoi, J., 1998, Expression of adult T cell leukemia-derived factor in human brain and peripheral nerve tissues. Dement. Geriatr. Cogn. Disord. 9: 181–185.
Bai, J., Nakamura, H., Hattori, I., Tanito, M., Yodoi, J., 2002, Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci. Lett. 321: 81–84.
Beal, M. F., 1995, Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38: 357–366.
Beal, M.F., Ferrante, R.J., Browne, S.E., Matthews, R.T., Kowall, N.W., Brown, R.H.,Jr., 1997, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42: 644–654.
Bellomo, G., Mirabelli, F., Vairetti, M, Iosi, F, Malorni, W., 1990, Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J. Cell. Physiol. 143: 118–128.
Bryk, R., Griffin, P., Nathan, C., 2000, Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407: 211–215.
Chen, W., Ji, J., Ru, B., 2005, Proteomic analysis of corticobasal degeneration: a case study of corticobasal degeneration at the proteome level. J. Neuropsychiatry Clin. Neurosci. 17: 364–371.
Chen, W., Ji, J., Xu, X., He, S., Ru, B., 2003, Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int. J. Dev. Neurosc.i 21: 209–216.
Demirkaya, S., Topcuoglu, M.A., Aydin, A., Ulas, U.H., Isimer, A.I., 2001, Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur. J. Neurol. 8: 43–51.
Dexter, D.T., Holley, A.E., Flitter, W.D., Slater, T.F., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P., Marsden, C.D., 1994, Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9: 92–97.
Dyrks, T., Dyrks, E., Masters, C.L., Beyreuther, K., 1993, Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett. 324: 231–236.
Eftekharpour, E., Holmgren, A., Juurlink, B H., 2000, Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons. Glia 31: 241–248.
Ferrante, R. J., Browne, S.E., Shinobu, L.A., Bowling, A.C., Baik, M.J., MacGarvey, U., Kowall, N.W., Brown, R.H., Jr., Beal, M.F., 1997, Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69: 2064–2074.
Floyd, R.A, Hensley, K., 2002, Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23: 795–807.
Hattori, F., Murayama, N., Noshita, T., Oikawa, S., 2003, Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J. Neurochem. 86: 860–868.
Hattori, I., Takagi, Y., Nozaki, K.,Kondo, N.,Bai, J., Nakamura, H., Hashimoto, N., Yodoi, J., 2002, Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Rep. 7: 256–259.
Ichimiya, S., Davis, J.G., O’Rourke, D.M., Katsumata, M., Greene, M.I., 1997, Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol. 16: 311–321.
Jin, M.H., Lee, Y.H., Kim, J.M., Sun, H.N., Moon, E.Y., Shong, M.H., Kim, S.U., Lee, S.H., Lee, T.H., Yu, D.Y., Lee, D.S., 2005, Characterization of neural cell types expressing peroxiredoxins in mouse brain. Neurosci. Lett. 381: 252–257.
Kikuchi, S., Shinpo, K., Takeuchi, M., Tsuji, S., Yabe, I., Niino, M., Tashiro, K., 2002, Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons. J. Neurosci. Res. 69: 373–381.
Kim, S. H., Fountoulakis, M., Cairns, N., Lubec, G., 2001, Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down syndrome. J. Neural. Transm. Suppl (61): 223–235.
Kopacek, J., Sakaguchi, S., Shigematsu, K., Nishida, N., Atarashi, R., Nakaoke, R., Moriuchi, R., Niwa, M., Katamine, S., 2000, Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J. Virol. 74: 411–417.
Krapfenbauer, K., Engidawork, E., Cairns, N., Fountoulakis, M., Lubec, G., 2003, Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 967: 152–160.
Krapfenbauer, K., Yoo, B.C., 2002, Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease. Electrophoresis 23: 2541–2547.
Lee, J. M., Shih, A.Y., Murphy, T.H., Johnson, J.A., 2003, NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem. 278: 37948–37956.
Lippoldt, A., Padilla, C.A., Gerst, H., Andbjer, B., Richter, E., Holmgren, A., Fuxe, K., 1995, Localization of thioredoxin in the rat brain and functional implications. J. Neurosci. 15: 6747–6756.
Liu, H., Uno, M., Kitazato, K.T., Suzue, A., Manabe, S., Yamasaki, H., Shono, M., Nagahiro, S., et al., 2004, Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction. Brain Res. 1025: 43–50.
Lovell, M. A., Ehmann, W.D., Butler, S.M., Markesbery, W.R., 1995, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology 45: 1594–1601.
Lovell, M.A., Xie, C., Gabbita, S.P., Markesbery, W.R., 2000, Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer’s disease brain. Free Radic. Biol. Med. 28: 418–427.
Mansur, K., Iwahashi, Y., Kiryu-Seo, S.Su., Q.Namikawa, K., Yodoi, J., Kiyama, H., 1998, Up-regulation of thioredoxin expression in motor neurons after nerve injury. Brain Res. Mol. Brain Res. 62: 86–91.
McIntosh, L.J., Trush, M.A., Troncoso, J. C., 1997, Increased susceptibility of Alzheimer’s disease temporal cortex to oxygen free radical-mediated processes. Free Radic. Biol. Med. 23: 183–190.
Mecocci, P., MacGarvey, U., Beal, M.F., 1994, Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann. Neurol. 36: 747–751.
Mitsui, A., Hamuro, J., Nakamura, H., Kondo, N., Hirabayashi, Y., Ishizaki-Koizumi, S., Hirakawa, T., Inoue, T., Yodoi, J., 2002, Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid. Redox Signal. 4: 693–696.
Mitsui, A., Hirakawa, T., Yodoi, J., 1992, Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186: 1220–1226.
Morimoto, T., Globus, M.Y., Busto, R., Martinez, E., Ginsberg, M. D., 1996, Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16: 92–99.
Nagayama, T., Lan, J., Henshall, D.C., Chen, D., O’Horo, C., Simon, R. P., Chen, J., 2000, Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75: 1716–1728.
Nakaso, K., Kitayama, M., Ishii, T., Bannai, S., Yanagawa, T., Kimura, K., Nakashima, K., Ohama, E., Yamada, K., 1999, Effects of kainate-mediated excitotoxicity on the expression of rat counterparts of A170 and MSP23 stress proteins in the brain. Brain Res. Mol. Brain Res. 69: 155–163.
Nakaso, K., Kitayama, M., Mizuta, E., Fukuda, H., Ishii, T., Nakashima, K., Yamada, K., 2000, Co-induction of heme oxygenase-1 and peroxiredoxin I in astrocytes and microglia around hemorrhagic region in the rat brain. Neurosci. Lett. 293: 49–52.
Nakaso, K., Yano, H., Fukuhara, Y., Takeshima, T., Wada-Isoe K., Nakashima K., 2003, PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett. 546: 181–184.
Nordberg, J., Arner, E.S., 2001, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31(: 1287–1312.
Patenaude, A., Murthy, M.R., Mirault, M.E., 2005, Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol. Life Sci. 62: 1063–1080.
Piantadosi, C. A., Zhang J., 1996, Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 27: 327–331; discussion 332.
Plaisant, F., Clippe, A., Van der Stricht, D., Knoops, B., Gressens, P., 2003, Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic. Biol. Med. 3: 862–872.
Powis, G., Montfort W.R., 2001, Properties and biological activities of thioredoxins. Ann. Rev. Pharmacol. Toxicol. 41: 261–295.
Powis, G., Mustacich, D., Coon, A., 2000, The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29: 312–322.
Rego, A.C., Monteiro, N.M., Silva, A.P., Gil, J., Malva, J.O., Oliveira, C.R., 2003, Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures. J. Neurochem. 86: 792–804.
Requena, J.R., Levine, R.L., 2001, Thioredoxin converts the Syrian hamster (29–231) recombinant prion protein to an insoluble form. Free Radic. Biol. Med. 30: 141–147.
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D.A., Hentati, A., Donaldson, D., Goto, J., O’Regan, J.P., Deng, H.X., 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59–62.
Rozell, B., Hansson, H.A., Luthman, M., Holmgren, A.,(1985, Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur. J. Cell Biol. 38: 79–86.
Rybnikova, E., Damdimopoulos, A.E., Gustafsson, J.A., Spyrou, G., Pelto-Huikko, M., 2000, Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur. J. Neurosci. 12: 1669–1678.
Sakamoto, A., Ohnishi, S.T., Ohnishi, T., Ogawa, R., 1991, Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res. 554: 186–192.
Sarafian, T.A., Verity, M.A., Vinters, H.V., Shih, C.C., Shi, L., Ji, X.D., Dong, L., Shau, H., 1999. Differential expression of peroxiredoxin subtypes in human brain cell types. J. Neurosci. Res. 56: 206–212.
Seo, M.S., Kang, S.W., Kim, K., Baines, I.C., Lee, T.H., Rhee, S.G., 2000, Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 275: 20346–20354.
Stemme, S., Hansson, H.A., Holmgren, A., Rozell, B., 1985, Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve. Brain Res. 359: 140–146.
Su, J.H., Deng, G., Cotman, C.W., 1997, Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer’s disease brain. Brain Res. 774: 193–199.
Takagi, Y., Hattori, I., Nozaki, K., Mitsui, A., Ishikawa, M., Hashimoto, N., Yodoi, J., 2000, Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. J. Cereb. Blood Flow Metab. 20: 829–833.
Takagi, Y., Horikawa, F., Nozaki, K., Sugino, T., Hashimoto, N., Yodoi, J., 1998, Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci. Lett. 251: 25–28.
Takagi, Y., Mitsui, A., Nishiyama, A., Nozaki, K., Sono, H., Gon, Y., Hashimoto, N., Yodoi, J., 1999, Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. USA 96: 4131–4136.
Takagi, Y., Tokime, T., Nozaki, K., Gon, Y., Kikuchi, H., Yodoi, J., 1998, Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: immunohistochemical and hybridization studies of thioredoxin. J. Cereb. Blood Flow Metab. 18: 206–214.
Tomimoto, H., Akiguchi, I., Wakita, H., Kimura, J., Hori, K., Yodoi, J., 1993, Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res. 625: 1–8.
Troncoso, J.C., Costello, A., Watson, A.L., Jr., Johnson, G.V., 1993, In vitro polymerization of oxidized tau into filaments. Brain Res. 613: 313–316.
Watabe, S., Hiroi, T., Yamamoto, Y., Fujioka, Y., Hasegawa, H., Yago, N., Takahashi, S.Y., 1997, SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur. J. Biochem. 249: 52–60.
White, B.C., Daya, A.. DeGracia, D.J., O’Neil, B.J., Skjaerlund, J.M., Trumble, S., Krause, G.S., Rafols, J.A., 1993, Fluorescent histochemical localization of lipid peroxidation during brain reperfusion following cardiac arrest. Acta Neuropathol.(Berl.) 86: 1–9.
Wood, Z.A., Schroder, E., Harris, J.R., Poole, L.B., 2003, Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28: 32–40.
Yamagata, K., Tagami, M., Ikeda, K.Yamori, Y. Nara, Y., 2000, Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 284: 131–134.
Yang, K.S., Kang, S.W., Woo, H.A, Hwang, S.C., Chae, H.Z., Kim, K., Rhee, S.G., 2002, Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277: 38029–38036.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E.R., Mizuno, Y., 1996, Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93: 2696–2701.
Zhou, Y., Zhang, W., Easton, R., Ray, J.W, Lampe, P, .Jiang, Z., Brunkan, A.L., Goate, A, Johnson, E M., Wu, J.Y., 2002, Presenilin-1 protects against neuronal apoptosis caused by its interacting protein PAG. Neurobiol. Dis. 9: 126–38.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Hattori, F., Oikawa, S. (2007). Peroxiredoxins in the Central Nervous System. In: Flohé, L., Harris, J.R. (eds) Peroxiredoxin Systems. Subcellular Biochemistry, vol 44. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6051-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6051-9_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6050-2
Online ISBN: 978-1-4020-6051-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)